Dare Bioscience Inc Share Price Today: Live Updates & Key Insights

Dare Bioscience Inc share price today is $1.27, up 1.59%. The stock opened at $1.255 against the previous close of $1.26, with an intraday high of $1.34 and low of $1.2301.

Dare Bioscience Inc Share Price Chart

Dare Bioscience Inc

us-stock
To Invest in {{usstockname}}
us-stock

Dare Bioscience Inc Share Price Performance

$1.27 0.0159(1.59%) DARE at 27 Jul 2026 02:37 PM Biotechnology
Lowest Today 1.2301
Highest Today 1.34
Today’s Open 1.255
Prev. Close 1.26
52 Week High 3.78
52 Week Low 1.16
Day’s Range: Low 1.2301 High 1.34
52-Week Range: Low 1.16 High 3.78
1 day return -
1 Week return -4.13
1 month return -38.99
3 month return -43.58
6 month return -33.24
1 year return -49.8
3 year return +67.82
5 year return -13.26
10 year return -

Dare Bioscience Inc Institutional Holdings

Vanguard Group Inc 3.49

Vanguard Total Stock Mkt Idx Inv 3.15

Vanguard Capital Management, LLC 3.09

Geode Capital Management, LLC 1.19

Vanguard Institutional Extnd Mkt Idx Tr 1.08

U.S. Bancorp 0.61

Fidelity Extended Market Index 0.52

Vanguard Fiduciary Trust Co 0.44

iShares Micro-Cap ETF 0.30

UBS Group AG 0.29

Fidelity Series Total Market Index 0.22

State Street Corp 0.16

XTX Topco Ltd 0.15

NT Ext Equity Mkt Index Fund - Lending 0.13

Two Sigma Advisers, LLC 0.12

Susquehanna International Group, LLP 0.11

BlackRock Inc 0.11

Blackrock Extended Mkt Fund CF 0.11

Extended Equity Market Fund B 0.11

Extended Equity Market Fund E 0.11

Northern Trust Corp 0.10

Fidelity Total Market Index 0.10

NT Ext Equity Mkt Index Fund - NL 0.10

LPL Financial Corp 0.10

BlackRock Extended Equity Market Fund K 0.09

T. Rowe Price U.S. Equities Tr 0.09

Two Sigma Investments LLC 0.09

Objectivity Squared LLC 0.07

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.07

T. Rowe Price Associates, Inc. 0.07

Renaissance Technologies Corp 0.07

Spartan Total Market Index Pool G 0.07

Vanguard Balanced Index Inv 0.05

Northern Trust Extended Eq Market Idx 0.05

Fidelity Nasdaq Composite Index 0.05

DFA US Small Cap I 0.03

State St US Extended Mkt Indx NL Cl C 0.02

Vanguard Global Advisers, LLC 0.02

IFS Advisors, LLC 0.01

SBI Securities Co Ltd 0.00

Dare Bioscience Inc Market Status

Strong Buy: 2

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

Dare Bioscience Inc Fundamentals

Market Cap 18.87 M

PB Ratio 25.9255

PE Ratio 0.0

Enterprise Value 2.12 M

Total Assets 32.47 M

Volume 197232

Dare Bioscience Inc Company Financials

Annual Revenue FY23:1000000 1.0M, FY22:10000000 10.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:10000000 10.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-41047052 -41.0M, FY22:406802262 406.8M, FY21:-38326218 -38.3M, FY20:-27400743 -27.4M, FY19:-14263830 -14.3M

Quarterly Revenue Q1/2026:152455 0.2M, Q3/2025:2262 0.0M, Q2/2025:-21172 -0.0M, Q1/2025:25427 0.0M, Q3/2024:41691 0.0M

Quarterly Profit Q1/2026:-644513 -0.6M, Q3/2025:-610602 -0.6M, Q2/2025:-21172 -0.0M, Q1/2025:-2271954 -2.3M, Q3/2024:41691 0.0M

Quarterly Net worth Q1/2026:-2999889 -3.0M, Q3/2025:-3562766 -3.6M, Q2/2025:-4016483 -4.0M, Q1/2025:-4378307 -4.4M, Q3/2024:-4702501 -4.7M

About Dare Bioscience Inc & investment objective

Company Information Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert to treat genital human papillomavirus (HPV) infection, cervical intraepithelial neoplasia, and other HPV-related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1 and DARE-PTB1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB2 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; and DARE-GML, which delivers antimicrobial glycerol monolaurate intravaginally. Daré Bioscience, Inc. was founded in 2015 and is headquartered in San Diego, California.

Organisation Biotechnology

Employees 21

Industry Biotechnology

CEO Ms. Sabrina Martucci Johnson

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Dare Bioscience Inc FAQs

What is the share price of Dare Bioscience Inc today?

The current share price of Dare Bioscience Inc is $1.27.

Can I buy Dare Bioscience Inc shares in India?

Yes, Indian investors can buy Dare Bioscience Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Dare Bioscience Inc shares in India?

You can easily invest in Dare Bioscience Inc shares from India by:

Can I buy fractional shares of Dare Bioscience Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Dare Bioscience Inc?

Dare Bioscience Inc has a market cap of $18.87 M.

In which sector does Dare Bioscience Inc belong?

Dare Bioscience Inc operates in the Biotechnology sector.

What documents are required to invest in Dare Bioscience Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Dare Bioscience Inc?

The PE ratio of Dare Bioscience Inc is N/A and the PB ratio is 25.93.